3Y Annualised Return
▲74.30%
5Y Annualised Return
▲64.08%
10Y Annualised Return
▲17.62%
Novelix Pharmaceuticals Stock Performance
|
|
|
Novelix Pharmaceuticals Company background
Founded in: 1994
Trimurthi Limited was formerly incorporated on December 13, 1994 with the name Trimurthi Securities Ltd. The name of the Company thereafter got changed from Trimurthi Securities Ltd to Trimurthi Drugs Pharmaceuticals Ltd. In September 2006, as per the Scheme of Arrangement, the erstwhile Trimurthi Drugs Pharmaceuticals Ltd amalgamated with the Company. Also, the name of the Company was changed to Trimurthi Drugs Pharmaceuticals Ltd and again to Trimurthi Limited in May, 2016.Initially, the company was engaged in finance and investments in securities. They ceased their operations due to the high volatility in the markets and voluntarily got deregistered as NonBanking financial company. Thereafter, the company explored the possibilities of entering into pharmaceutical and drug industry by way of diversification.In November 2009, the Company received NSEN ISO 9001:2008 / ISO 9001:2008 for marketing and distribution of pharmaceutical products from Kvalitet Veritas Quality Assurance. They had been appointed as Authorized Distributors on all India level for Livewell Food products and ABLE, Pharma, in the Salon District of Himachal Pradesh.During the year 201011, the Company started their first Pharmacy Retail Outlet in Himayath Nagar, Hyderabad. Also, they started their second retail outlet at Inderbagh, Sultan Bazar, Hyderabad. The Company with its full capacity commenced the business operations in food industry business through its wholly owned subsidiary in 2018.The Company started their operations in State of West Bengal. Also, they started marketing of their products in Assam and with that they marked their presence in the eastern part of India.
Novelix Pharmaceuticals Financial Highlights
Novelix Pharmaceuticals reported a Q2 FY2022–2023 revenue of ₹1.24 crore, down -4.5% YoY, with net profit decreased -43.6% to ₹-0.14 crore. For the full year FY2022–2023, revenue reached ₹9.16 crore and profit touched at ₹-2.11 crore. As of Jun '25, Novelix Pharmaceuticals ’s market capitalisation stood at ₹99.08 crores. Shareholding as of Jun '25 shows promoters holding 52.8%, with FIIs at 47.2%, DIIs at %, and public at %.
As of 14 Aug, 2025, Novelix Pharmaceuticals share price is ₹39.7. The stock opened at ₹39.9 and had closed at ₹40 the previous day. During today’s trading session, Novelix Pharmaceuticals share price moved between ₹39.00 and ₹42.00, with an average price for the day of ₹40.50. Over the last 52 weeks, the stock has recorded a low of ₹20.87 and a high of ₹52.79. In terms of performance, Novelix Pharmaceuticals share price has increased by 56.6% over the past six months and has increased by 91.66% over the last year.
Novelix Pharmaceuticals SIP Return Calculator
Over the past
3 years
5 years
Total Investment of ₹1,95,00,000
Would have become ₹7,24,77,118 (+271.68%)
Daily SIP of ₹25,000 would have become ₹7,24,77,118 in 3 years with a gain of ₹5,29,77,118 (+271.68%)
Novelix Pharmaceuticals Fundamental
Market Cap (in crs)
99.08
Face Value
10
Turnover (in lacs)
6.40
Key Metrics
Qtr Change %
90.27% Gain from 52W Low
42.1
Dividend yield 1yr %
0
Novelix Pharmaceuticals Key Financials
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Novelix Pharmaceuticals Quarterly Revenue
| Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 |
|---|---|---|---|---|
1.24 Cr | 1.36 Cr | 0.69 Cr | 1.11 Cr | 2.46 Cr |
Novelix Pharmaceuticals Yearly Revenue
| Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|
9.16 Cr | 9.59 Cr | 10.85 Cr | 10.84 Cr | 10.71 Cr | 9.35 Cr |
Novelix Pharmaceuticals Quarterly Net Profit/Loss
| Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 |
|---|---|---|---|---|
-0.14 Cr | -0.11 Cr | -1.6 Cr | -0.7 Cr | 0.35 Cr |
Novelix Pharmaceuticals Yearly Net Profit/Loss
| Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|
-2.11 Cr | -3.74 Cr | -0.26 Cr | -0.15 Cr | -0.35 Cr | 0.03 Cr |
Novelix Pharmaceuticals Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
0.00
Current Price
5Day EMA
40.40
10Day EMA
41.00
12Day EMA
41.20
20Day EMA
41.50
26Day EMA
41.20
50Day EMA
38.30
100Day EMA
32.00
200Day EMA
24.60
5Day SMA
40.60
10Day SMA
40.80
20Day SMA
42.20
30Day SMA
43.70
50Day SMA
38.70
100Day SMA
30.20
150Day SMA
24.00
200Day SMA
20.40
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 16119 Rs | 16119 Rs |
Week Rs | 4610 Rs | 4610 Rs |
Month Rs | 8382 Rs | 8382 Rs |
Resistance & Support
40.24
Pivot
Resistance
First Resistance
41.47
Second Resistance
43.24
Third Resistance
44.47
Support
First Support
38.47
Second support
37.24
Third Support
35.47
Relative Strength Index
45.42
Money Flow Index
55.45
MACD
0.01
MACD Signal
0.69
Average True Range
2.89
Average Directional Index
32.82
Rate of Change (21)
-16.75
Rate of Change (125)
342.70
Novelix Pharmaceuticals Peer comparison
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
- | 62.22 | 14.72 | 36.71 | 19.17 | -3.21% | -14.01% | -9.26% | -26.82% | 5.86% | 0.00% | 0.00 | 205.19 | 0.49 | |
- | 44.01 | 3.9 | 12.36 | 7.18 | 23.65% | 47.36% | 53.05% | 28.72% | 100.80% | 0.00% | 0.00 | 205.19 | 9.48 | |
- | 62.14 | 31.01 | 85 | 42.46 | -0.09% | -17.62% | 7.49% | -46.31% | 0.74% | 0.00% | 0.00 | 205.19 | 3.00 | |
Cell Point (India) Ltd. | 17.35 | 17.35 | - | - | - | - | - | - | - | - | - | - | - | - |
Fonebox Retail Ltd. | 82.50 | 82.50 | - | - | - | - | - | - | - | - | - | - | - | - |
- | 32.00 | 31.5 | 57 | 39.61 | 2.60% | 7.47% | 17.61% | -0.15% | 0.00% | 0.00% | 285.57 | 205.19 | 1.35 |
Novelix Pharmaceuticals Share Price FAQs
How to buy Novelix Pharmaceuticals shares?
You can easily buy Novelix Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Novelix Pharmaceuticals ?
The 52-week high and low of Novelix Pharmaceuticals share price is ₹52.79 and ₹20.87 as of 14/8/2025.
Please be aware that Novelix Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account